Ad is loading...
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
RREMX
Price
$13.50
Change
-$0.04 (-0.30%)
Updated
Nov 15 closing price
Ad is loading...

RNWFX vs RREMX

Header iconRNWFX vs RREMX Comparison
Open Charts RNWFX vs RREMXBanner chart's image
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
RBC Emerging Markets Equity R6
Price$13.50
Change-$0.04 (-0.30%)
VolumeN/A
CapitalizationN/A
RNWFX vs RREMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. RREMX commentary
Nov 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Hold and RREMX is a Sell.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. RREMX (3.49B). RREMX (1.57) and RNWFX (1.51) have matching dividends . RNWFX was incepted earlier than RREMX: RNWFX (23 years) vs RREMX (8 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. RREMX (19.00). RNWFX has a lower initial minimum investment than RREMX: RNWFX (250) vs RREMX (250000). RREMX annual gain was more profitable for investors over the last year : 13.37 vs. RNWFX (11.54). RREMX return over 5 years is better than : 19.01 vs. RNWFX (17.17).
RNWFXRREMXRNWFX / RREMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years8 years-
Gain YTD7.0997.48495%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B3.49B1,744%
Annual Yield % from dividends1.511.5796%
Returns for 1 year11.5413.3786%
Returns for 3 years-14.55-1.411,034%
Returns for 5 years17.1719.0190%
Returns for 10 years41.00N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics